MedPath

Fenolex

Brand Name: Fenolex

Generic Name: Guaifenesin/ Salbutamol (as Sulfate)

Active
Registration Number

DRP-2153-03

Dosage Form

Capsule

Issuance Date

March 1, 2024

Expiry Date

April 28, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100mg/2mg
PackagingAlu-Foil Strip x 4's (Box of 100's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Expectorant/ Antiasthma
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Guaifenesin/ Salbutamol (as Sulfate)Active
Monograph: guaifenesin/ salbutamol (as sulfate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform